ZAGREB, February 21, 2017 (Hina) - The US pharmaceutical company Pfizer will close the Australian plant which produces the API for HSP-130, a candidate version of Amgen’s Neulasta, and shift production to Croatia, Pfizer told Hina.
(Hina) its
NEWS BULLETIN NO. 12792
Imposing topic of EU enlargement is Croatia's political success, says PM
No one has right to reject outstretched hand, says MP Benčić
ZSE: Crobex indices end 6-day rise
Opposition rejects Vučić's proposal to test voter confidence in a referendum
News schedule for Thursday, 16 January
Recording of Judita available on OperaVision as of Friday
Success of peaceful reintegration not as valued as military operations, panel hears
Air force component of Croatian contingent deployed to NATO mission in Kosovo
"Sons, Daughters" by I. Bodrožić added to longlist of Dublin Literary Award
ZAGREB, February 21, 2017 (Hina) - The US pharmaceutical company Pfizer will close the Australian plant which produces the API for HSP-130, a candidate version of Amgen’s Neulasta, and shift production to Croatia, Pfizer told Hina.
(Hina) its